Wilmer Cutler Pickering Hale and Dorr advised Eliem Therapeutics on the deal, and Cooley advised Tenet Medicines. Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced that it had entered into...
Eliem Therapeutics’ Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
Paul, Weiss Adds Leading Latin America M&A Partner in New York
Paul, Weiss, Rifkind, Wharton & Garrison LLP announced that Maria-Leticia Ossa Daza has joined the firm as a partner in the Mergers & Acquisitions practice in...
Nationally Recognized Life Sciences Patent Litigation Team Joins Mintz
A leading life sciences patent litigation team has joined Mintz. The team is led by Siegmund (“Sige”) Gutman, who will serve as Member, Chair of Life Sciences Litigation, and...
Genesee & Wyoming’s $4 Billion Debt Offering
Kirkland & Ellis represented Genesee & Wyoming Inc. in the deal. Genesee & Wyoming Inc., a short-line railroad holding company and a portfolio company of Brookfield...
Bonaccord Capital Partners’ Minority Investment in Lead Edge Capital
Kirkland & Ellis and Goodwin Procter advised Lead Edge Capital on the transaction, and Fried, Frank, Harris, Shriver & Jacobson advised Bonaccord Capital Partners. Lead Edge...
OrbiMed’s $50 Million Financing
Covington & Burling represented OrbiMed Advisors, LLC in the transaction. OrbiMed Advisors, LLC, a healthcare investment firm, announced a debt financing facility for up to $50...
EQT Private Equity Asia’s Acquisition of WSO2
Ropes & Gray advised EQT Private Equity Asia on the transaction, and Cooley advised WSO2. EQT Private Equity Asia announced it has entered into an agreement to...
Enlaza Therapeutics’ $100 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Enlaza on IP matters related to the transaction. Enlaza Therapeutics (Enlaza), the first covalent biologic platform company, announced it closed...
Reunion Neuroscience’s $103 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Novo Holdings on the transaction. Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, announced the close of a $103 million Series A...
Alethea’s $20 Million Series B Funding Round
Wilmer Cutler Pickering Hale and Dorr represented Alethea in the transaction. Alethea, a leading technology company in disinformation detection and mitigation, announced it has raised $20 million in Series...
Eniac Ventures’ $220 Million Fund Formations
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Eniac Ventures in the deal. Eniac Ventures, a seed-stage firm, announced the formation of its new $160M Eniac Ventures...
Duro’s $7.5 Million Seed Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Duro in the transaction. Duro, a leading Cloud-native PLM platform in hardware engineering, announced it has raised $7.5 million...